• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neurology . Persistent Autonomic and Immunologic Abnormalities in Neurologic Post-Acute Sequelae of SARS-CoV2 Infection

tetano

Editor, Senior Moderator
Neurology


. 2024 Sep 24;103(6):e209742.
doi: 10.1212/WNL.0000000000209742. Epub 2024 Aug 22. Persistent Autonomic and Immunologic Abnormalities in Neurologic Post-Acute Sequelae of SARS-CoV2 Infection

David S Goldstein[SUP] 1 [/SUP], Yair Mina[SUP] 1 [/SUP], Brian Walitt[SUP] 1 [/SUP], Patti Sullivan[SUP] 1 [/SUP], Yoshimi Enose-Akahata[SUP] 1 [/SUP], Steven Jacobson[SUP] 1 [/SUP], My-Le Nguyen[SUP] 1 [/SUP], Stanislav Sidenko[SUP] 1 [/SUP], Amanda Wiebold[SUP] 1 [/SUP], Bryan Smith[SUP] 1 [/SUP], Janna Gelsomino[SUP] 1 [/SUP], Risa Isonaka[SUP] 1 [/SUP], Sarah Moore[SUP] 1 [/SUP], Avindra Nath[SUP] 1 [/SUP]



Affiliations
Abstract

Objectives: After acute coronavirus disease-2019 (COVID-19), people often experience fatigue, "brain fog," or other central neurologic symptoms (neuro-post-acute SARS-CoV2, or "Neuro-PASC"). In this observational study we evaluated whether abnormalities noted on initial evaluation persist after at least another year.
Methods: Neuro-PASC research participants who had undergone comprehensive inpatient testing at the NIH Clinical Center returned after at least 1 year for follow-up assessments including symptoms rating scales, MRI, lumbar puncture for tests of the CSF, physiologic recordings during the Valsalva maneuver and head-up tilting (with serial plasma catechols and cardiac Doppler ultrasound during the tilting), blood volume measurement, skin biopsies to examine sympathetic innervation, and blood sampling for neuroendocrine and immunologic measures.
Results: 7 patients with Neuro-PASC (6 women, age range 42-63 years) underwent follow-up testing. 71% of initially abnormal test results remained abnormal at follow-up, including the pattern of CSF and serum oligoclonal bands, CSF indices of central catecholamine deficiency, baroreflex-cardiovagal dysfunction, the occurrence of tilt-evoked sudden hypotension, white matter hyperintensities on MRI, and adaptive responses in CSF.
Discussion: In Neuro-PASC most of the autonomic and immunologic abnormalities found initially are still present after more than a year.


 
Back
Top Bottom